title: CD11b⁺, Ly6G⁺ cells produce type I interferon and exhibit tissue protective properties following peripheral virus infection.
abstract: The goal of the innate immune system is containment of a pathogen at the site of infection prior to the initiation of an effective adaptive immune response. However, effector mechanisms must be kept in check to combat the pathogen while simultaneously limiting undesirable destruction of tissue resulting from these actions. Here we demonstrate that innate immune effector cells contain a peripheral poxvirus infection, preventing systemic spread of the virus. These innate immune effector cells are comprised primarily of CD11b⁺Ly6C⁺Ly6G⁻ monocytes that accumulate initially at the site of infection, and are then supplemented and eventually replaced by CD11b⁺Ly6C⁺Ly6G⁺ cells. The phenotype of the CD11b⁺Ly6C⁺Ly6G⁺ cells resembles neutrophils, but the infiltration of neutrophils typically occurs prior to, rather than following, accumulation of monocytes. Indeed, it appears that the CD11b⁺Ly6C⁺Ly6G⁺ cells that infiltrated the site of VACV infection in the ear are phenotypically distinct from the classical description of both neutrophils and monocyte/macrophages. We found that CD11b⁺Ly6C⁺Ly6G⁺ cells produce Type I interferons and large quantities of reactive oxygen species. We also observed that depletion of Ly6G⁺ cells results in a dramatic increase in tissue damage at the site of infection. Tissue damage is also increased in the absence of reactive oxygen species, although reactive oxygen species are typically thought to be damaging to tissue rather than protective. These data indicate the existence of a specialized population of CD11b⁺Ly6C⁺Ly6G⁺ cells that infiltrates a site of virus infection late and protects the infected tissue from immune-mediated damage via production of reactive oxygen species. Regulation of the action of this population of cells may provide an intervention to prevent innate immune-mediated tissue destruction.
authors.affiliation: Department of Microbiology and Immunology, Pennsylvania State University Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States of America.
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Fischer
authors.forename: Michael L
authors.initials: ML
authors.lastname: Davies
authors.forename: Irene E
authors.initials: IE
authors.lastname: Reider
authors.forename: Erica L
authors.initials: EL
authors.lastname: Heipertz
authors.forename: Melanie R
authors.initials: MR
authors.lastname: Epler
authors.forename: Janet J
authors.initials: JJ
authors.lastname: Sei
authors.forename: Molly A
authors.initials: MA
authors.lastname: Ingersoll
authors.forename: Nico Van
authors.initials: NV
authors.lastname: Rooijen
authors.forename: Gwendalyn J
authors.initials: GJ
authors.lastname: Randolph
authors.forename: Christopher C
authors.initials: CC
authors.lastname: Norbury
mesh_terms: D000818:Animals; D000950:Antigens, Ly / Q000032:analysis; D039481:CD11b Antigen / Q000032:analysis; D007113:Immunity, Innate; D007370:Interferon Type I / Q000096:biosynthesis* / Q000276:immunology; D008264:Macrophages / Q000276:immunology / Q000821:virology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009000:Monocytes / Q000276:immunology* / Q000821:virology; D009504:Neutrophils / Q000276:immunology* / Q000821:virology; D017382:Reactive Oxygen Species / Q000378:metabolism; D014615:Vaccinia / Q000276:immunology* / Q000821:virology; D014616:Vaccinia virus / Q000276:immunology* / Q000472:pathogenicity
chemical_list: D000950:Antigens, Ly; D039481:CD11b Antigen; D007370:Interferon Type I; C480309:Ly6G antigen, mouse; D017382:Reactive Oxygen Species
references.citation: Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8798-803
references.pmid: 11447290
references.citation: Cell. 2002 May 31;109(5):625-37
references.pmid: 12062105
references.citation: J Immunol. 2008 Oct 15;181(8):5791-802
references.pmid: 18832739
references.citation: J Leukoc Biol. 2008 Jan;83(1):64-70
references.pmid: 17884993
references.citation: Biochim Biophys Acta. 2008 Nov;1780(11):1348-61
references.pmid: 18249195
references.citation: J Infect Dis. 2003 May 15;187(10):1609-15
references.pmid: 12721941
references.citation: Wound Repair Regen. 2009 Jan-Feb;17(1):1-18
references.pmid: 19152646
references.citation: J Immunol Methods. 1994 Sep 14;174(1-2):83-93
references.pmid: 8083541
references.citation: Nat Immunol. 2002 Mar;3(3):265-71
references.pmid: 11828323
references.citation: J Exp Med. 2003 May 19;197(10):1269-78
references.pmid: 12756265
references.citation: Eur J Immunol. 2006 Jun;36(6):1364-73
references.pmid: 16703568
references.citation: Nat Rev Immunol. 2006 Mar;6(3):173-82
references.pmid: 16498448
references.citation: Cell. 1995 May 19;81(4):641-50
references.pmid: 7538909
references.citation: Nature. 2007 Nov 1;450(7166):110-4
references.pmid: 17934446
references.citation: Immunity. 2007 Apr;26(4):519-31
references.pmid: 17412618
references.citation: Nat Rev Immunol. 2010 Jun;10(6):427-39
references.pmid: 20498669
references.citation: Nat Rev Immunol. 2010 Jun;10(6):453-60
references.pmid: 20467425
references.citation: J Immunol. 2003 Sep 15;171(6):3034-46
references.pmid: 12960329
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10925-30
references.pmid: 9380736
references.citation: J Immunol. 2004 May 15;172(10):6265-71
references.pmid: 15128815
references.citation: J Exp Med. 1995 Jun 1;181(6):2171-9
references.pmid: 7539042
references.citation: Virchows Arch. 2003 Dec;443(6):703-17
references.pmid: 14586652
references.citation: J Gen Virol. 1999 Oct;80 ( Pt 10):2751-2755
references.pmid: 10573171
references.citation: J Immunol. 2000 Jul 15;165(2):779-85
references.pmid: 10878351
references.citation: Mol Med. 1996 Nov;2(6):692-701
references.pmid: 8972484
references.citation: Circ Res. 2006 Oct 27;99(9):943-50
references.pmid: 17008602
references.citation: J Exp Med. 1987 Dec 1;166(6):1685-701
references.pmid: 2445894
references.citation: J Exp Med. 2006 Mar 20;203(3):583-97
references.pmid: 16492803
references.citation: Immunity. 2003 Jul;19(1):71-82
references.pmid: 12871640
references.citation: Nat Immunol. 2009 Nov;10(11):1200-7
references.pmid: 19801985
references.citation: Virology. 2007 Jun 20;363(1):48-58
references.pmid: 17331554
references.citation: Nat Rev Immunol. 2005 Dec;5(12):905-16
references.pmid: 16239901
references.citation: Immunity. 2010 Aug 27;33(2):266-78
references.pmid: 20727790
references.citation: J Virol. 2000 Apr;74(7):3404-9
references.pmid: 10708458
references.citation: J Leukoc Biol. 2008 Sep;84(3):644-50
references.pmid: 18611985
references.citation: J Gen Virol. 2010 Sep;91(Pt 9):2158-66
references.pmid: 20538903
references.citation: Nat Genet. 1995 Feb;9(2):202-9
references.pmid: 7719350
references.citation: Immunity. 2008 Aug 15;29(2):306-17
references.pmid: 18691912
references.citation: J Immunol. 2009 May 1;182(9):5693-701
references.pmid: 19380816
references.citation: Immunity. 2009 Feb 20;30(2):277-88
references.pmid: 19200757
references.citation: J Leukoc Biol. 2004 Apr;75(4):612-23
references.pmid: 14726498
references.citation: J Immunol. 1993 Sep 1;151(5):2399-408
references.pmid: 8360469
references.citation: J Gen Virol. 2002 Aug;83(Pt 8):1977-1986
references.pmid: 12124461
references.citation: Chest. 1999 Jul;116(1 Suppl):61S-63S
references.pmid: 10424595
references.citation: Inflamm Res. 2006 May;55(5):200-6
references.pmid: 16830107
references.citation: Immunol Rev. 1995 Dec;148:5-18
references.pmid: 8825279
references.citation: Virology. 2000 Nov 25;277(2):439-49
references.pmid: 11080491
references.citation: J Exp Med. 1997 Nov 3;186(9):1591-6
references.pmid: 9348317
references.citation: Nature. 2010 Jun 24;465(7301):1079-83
references.pmid: 20577213
references.citation: Expert Rev Vaccines. 2008 Oct;7(8):1201-14
references.pmid: 18844594
references.citation: Virology. 2010 Nov 10;407(1):143-51
references.pmid: 20817252
references.citation: J Immunol. 2004 Jan 15;172(2):989-99
references.pmid: 14707072
references.citation: Cell Host Microbe. 2010 Aug 19;8(2):174-85
references.pmid: 20709294
references.citation: J Exp Med. 2008 Sep 29;205(10):2319-37
references.pmid: 18779347
references.citation: Am J Physiol Gastrointest Liver Physiol. 2000 Feb;278(2):G259-65
references.pmid: 10666050
references.citation: J Gen Virol. 2006 May;87(Pt 5):1157-1161
references.pmid: 16603516
references.citation: Free Radic Biol Med. 2009 Mar 15;46(6):791-8
references.pmid: 19124074
references.citation: Circ Res. 2001 Jul 20;89(2):168-73
references.pmid: 11463724
references.citation: Eur J Immunol. 1988 Nov;18(11):1819-26
references.pmid: 2849552
references.citation: Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3458-62
references.pmid: 8159769
references.citation: J Gen Virol. 2003 Aug;84(Pt 8):1973-1983
references.pmid: 12867627
references.citation: Expert Rev Vaccines. 2008 Nov;7(9):1329-39
references.pmid: 18980537
references.citation: J Virol. 1995 Feb;69(2):910-5
references.pmid: 7529336